In summary, advancements in cGAS stimulators, such as Svg3, manganese, and eribulin, as well as the emergence of nanocomposites for targeted drug delivery have proven promising for enhancing immune responses against diseases, particularly cancers, by effectively targeting the cGAS-STING pathway. This evidence concerns the gene CGAS and cancer.